EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Screening of Rubella Virus, Cytomegalovirus, Hepatitis B Virus, Hepatitis C Virus, HIV, Syphilis, and Toxoplasma gondii Antibodies in Pregnant Women

Fatih Mehmet Akıllı iD, Fatih Demir iD, Taylan Onat iD

Viruses · 2026

DOI: 10.3390/v18020206 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Viruses, 2026. Verfasst von Fatih Mehmet Akıllı und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Microbiology, Sincan Training and Research Hospital, Health Sciences University, Ankara 34668, Turkey. Hauptthemen laut MEDLINE: Antibodies, Viral, Pregnancy Complications, Infectious. Die Arbeit nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

TORCH pathogens are often asymptomatic in healthy adults but can cause foetal death when transmitted during pregnancy; therefore, accurate regional data are essential for screening. This study aimed to determine first-trimester TORCH seropositivity and to inform the development of hospital-based and national screening algorithms. This study analysed test results from 7481 pregnant women aged 15–49 years who participated between January 2020 and December 2024. TORCH serological results obtained using the MAGLUMI X3/X6 system (Snibe, Shenzhen, China) were analysed with Statistical Package for the Social Sciences. Anti-HCV positivity was 0.12% (9/7166), anti-Toxoplasma gondii IgG positivity was 16.5% (1027/6204), anti-rubella IgG positivity was 95.5% (5809/6080), and anti-CMV IgG positivity was 98.69% (6130/6211). Syphilis seropositivity among pregnant women was 0.2% (13/4991). Significant differences by age groups (15–24, 25–34, and >35 years) were observed for rubella IgG (p < 0.001), T. gondii IgG (p < 0.001), and HBsAg positivity (p = 0.009). This study investigated TORCH seropositivity among pregnant women in our hospital region and underscores the need for targeted public health initiatives to reduce the risk of congenital infections. It recommends systematic first-trimester assessment of TORCH exposure, standardized data recordings, the establishment of national screening programmes, and careful consideration of testing costs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antibodies, ViralPregnancy Complications, InfectiousFemaleHumansPregnancyAdultAdolescentSyphilisToxoplasmosisYoung AdultMiddle AgedToxoplasmaSeroepidemiologic StudiesImmunoglobulin GRubellaHIV InfectionsAntibodies, ProtozoanChinaRubella virusHepatitis CHepatitis BCytomegalovirus

Stichwörter der Autor:innen

TORCHVDRLcongenital infectionsepidemiologyprenatal screeningpublic healthseroprevalence

Substanzen

Antibodies, ViralImmunoglobulin GAntibodies, ProtozoanAntibodies, Bacterial

Autor:innen und Institutionen

  • Department of Medical Microbiology, Sincan Training and Research Hospital, Health Sciences University, Ankara 34668, Turkey.
  • Department of Medical Microbiology, Aksaray Training and Research Hospital, Aksaray 68200,Turkey.
  • Department of Obstetrics and Gynecology, Sincan Training and Research Hospital, Health Sciences University, Ankara 34668, Turkey.

ORCID-Profile: Fatih Mehmet Akıllı, Fatih Demir, Taylan Onat

Zitieren

APA

Akıllı, F. M., Demir, F., & Onat, T. (2026). Screening of Rubella Virus, Cytomegalovirus, Hepatitis B Virus, Hepatitis C Virus, HIV, Syphilis, and Toxoplasma gondii Antibodies in Pregnant Women. Viruses. https://doi.org/10.3390/v18020206

Vancouver

Akıllı FM, Demir F, Onat T. Screening of Rubella Virus, Cytomegalovirus, Hepatitis B Virus, Hepatitis C Virus, HIV, Syphilis, and Toxoplasma gondii Antibodies in Pregnant Women. Viruses. 2026. doi:10.3390/v18020206

BibTeX
@article{Akll2026,
  author = {Akıllı, Fatih Mehmet and Demir, Fatih and Onat, Taylan},
  title = {Screening of Rubella Virus, Cytomegalovirus, Hepatitis B Virus, Hepatitis C Virus, HIV, Syphilis, and Toxoplasma gondii Antibodies in Pregnant Women},
  journal = {Viruses},
  year = {2026},
  doi = {10.3390/v18020206}
}
Kostenlos starten →